How should a 48-year-old patient with a blood pressure of 148/90 mmHg and no other significant clinical findings be managed?

Management of a 48-Year-Old Patient with BP 148/90 mmHg

This patient has Stage 1 hypertension (148/90 mmHg) and should begin intensive lifestyle modifications immediately, with the decision to start pharmacological therapy determined by their 10-year cardiovascular disease risk using the PREVENT calculator. 1

Blood Pressure Classification

This patient's BP of 148/90 mmHg meets criteria for Stage 1 hypertension (systolic 140-159 mmHg or diastolic 90-99 mmHg per ESC guidelines, or 130-139/80-89 mmHg per ACC/AHA 2025 guidelines). 1, 2 The 2025 ACC/AHA guidelines would actually classify this as Stage 2 hypertension (≥140/90 mmHg), which has important treatment implications.

Immediate Management Steps

1. Confirm the Diagnosis

• Do not make treatment decisions based on a single office reading
• Confirm hypertension with out-of-office BP measurements (home BP monitoring or 24-hour ambulatory BP monitoring) 2
• Obtain multiple readings over 2-4 weeks before initiating pharmacotherapy unless BP is severely elevated

2. Cardiovascular Risk Assessment

Calculate the patient's 10-year cardiovascular disease risk using the PREVENT calculator 1. This is the critical decision point:

If PREVENT risk ≥7.5% OR presence of:

• Clinical cardiovascular disease
• Previous stroke
• Diabetes mellitus
• Chronic kidney disease

→ Start pharmacological therapy immediately along with lifestyle modifications 1

If PREVENT risk <7.5% AND no high-risk conditions: → Begin intensive lifestyle modifications for 3-6 months 1, 2 → If BP remains ≥130/80 mmHg after this trial, initiate medications 1

3. Baseline Evaluation Required

Obtain these specific tests before treatment decisions:

• Urinalysis (dipstick for protein)
• Serum creatinine and eGFR
• Fasting glucose or HbA1c
• Lipid panel
• ECG
• Electrolytes (sodium, potassium) 2

For this 48-year-old patient, also screen for secondary hypertension causes (particularly important in adults diagnosed before age 40, but reasonable to consider at 48 if other features suggest secondary causes) 2

Lifestyle Modifications (Mandatory for All Patients)

Implement these evidence-based interventions immediately 1, 2:

• DASH or Mediterranean diet - emphasize vegetables, fruits, whole grains, low-fat dairy
• Sodium restriction to <2 g/day (ideally <1.5 g/day)
• Increase dietary potassium unless contraindicated
• Weight loss if BMI >25 kg/m² - target BMI 20-25 kg/m², waist <94 cm (men) or <80 cm (women)
• Aerobic exercise 150 minutes/week moderate intensity, plus resistance training 2-3 times/week 2
• Alcohol reduction - limit to <100 g/week pure alcohol (approximately 7 standard drinks), ideally eliminate 2
• Tobacco cessation if applicable
• Stress management techniques

Pharmacological Treatment

When to Start Medications

Based on 2025 ACC/AHA guidelines 1:

• This patient (148/90 mmHg = Stage 2 by ACC/AHA) should start medications immediately if confirmed on repeat measurements, regardless of CV risk
• Target BP: <130/80 mmHg for all adults 1

Based on 2024 ESC guidelines 2:

• Start medications for confirmed BP ≥140/90 mmHg irrespective of CVD risk 2
• Target systolic BP: 120-129 mmHg if well tolerated 2

Initial Medication Strategy

For Stage 2 hypertension (≥140/90 mmHg), start with combination therapy 1, 2:

Preferred initial regimen:

• Single-pill fixed-dose combination of two agents (improves adherence) 1, 2
• RAS blocker (ACE inhibitor OR ARB) + dihydropyridine calcium channel blocker 2
• OR RAS blocker + thiazide/thiazide-like diuretic (chlorthalidone or indapamide preferred over hydrochlorothiazide) 2

First-line drug classes (all have equivalent cardiovascular outcomes) 2:

• ACE inhibitors
• Angiotensin receptor blockers (ARBs)
• Dihydropyridine calcium channel blockers
• Thiazide-type diuretics (chlorthalidone, indapamide)

Important Medication Considerations

• Never combine two RAS blockers (ACE inhibitor + ARB) - this is contraindicated 2
• Beta-blockers are NOT first-line unless compelling indication (post-MI, heart failure with reduced ejection fraction, angina, rate control) 2
• Timing of medication: Take at most convenient time to ensure adherence - no evidence that timing affects outcomes 2

If BP Not Controlled on Two Drugs

Escalate to three-drug combination 2:

• RAS blocker + dihydropyridine CCB + thiazide/thiazide-like diuretic
• Preferably as single-pill combination

If BP Not Controlled on Three Drugs

Add spironolactone as fourth agent 2

Blood Pressure Targets

Target BP: <130/80 mmHg (ACC/AHA 2025) 1

OR

Target systolic BP: 120-129 mmHg if well tolerated (ESC 2024) 2

Critical caveat: If diastolic BP falls below 70 mmHg, exercise caution due to increased risk of ischemic cardiac events 3

Follow-Up Strategy

• Recheck BP in 1-2 weeks after starting medication
• Home BP monitoring strongly recommended - improves control rates when combined with team-based care 1
• Adjust medications every 2-4 weeks until target achieved
• Once controlled, follow-up every 3-6 months
• Lifelong treatment - do not discontinue medications even if BP normalizes 2

Common Pitfalls to Avoid

1. Making treatment decisions on single office reading - always confirm with out-of-office measurements
2. Starting monotherapy for Stage 2 hypertension - combination therapy achieves control faster and improves adherence 1, 2
3. Using separate pills instead of fixed-dose combinations - reduces adherence 2
4. Neglecting lifestyle modifications - these are mandatory regardless of medication use
5. Not calculating cardiovascular risk - this determines treatment urgency in borderline cases
6. Overtreating diastolic BP - watch for values <70 mmHg
7. Using cuffless devices or smartwatches for BP measurement - insufficient accuracy 1